Thus, reducing the levels of V-ATPase would likely suppress migration of esophageal cancer cells by suppressingthe expression of Vimentin and MMP family proteins, which would be applicable for the development of potential therapeutic strategies against ESCC. Here, VIM is linked to esophageal squamous cell carcinoma.